A Clinical Trial of Observation versus Controlled Intermittent Alternate Occlusion (CIAO) Therapy using Amblyz Glasses for Intermittent Exotropia
Study on Eye Condition Treatment
Brief description of study.
The purpose of this study is to determine whether Controlled Intermittent Alternate Occlusion therapy associated with Amblyz glasses is effective in treating intermittent exotropia.
Detailed description of study
The purpose of this study is to determine whether Controlled Intermittent Alternate Occlusion therapy associated with Amblyz glasses is effective in treating intermittent exotropia.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Intermittent Exotropia
-
Age: 3 years - 11 years
-
Gender: All
This study investigates the effectiveness of Controlled Intermittent Alternate Occlusion therapy combined with special glasses in treating intermittent exotropia. Intermittent exotropia is a condition where one eye occasionally moves outward. The glasses used in this study are designed to help control this eye movement.
Participants in the study will use these special glasses as part of their treatment. The study aims to see how well the therapy works in managing the eye condition. No specific details about the procedures are provided in the description.
- Who can participate: The eligibility criteria for this study have not been specified. Please check with the study coordinators for more information.
- Study details: Participants will wear special glasses designed to control eye movement. The study will assess the effectiveness of this therapy in treating the condition. If a placebo is part of the study, it will be an inactive substance that looks like the investigational medicine/vaccine but does not contain any medicine.
Interested in the study?
Select a study center that’s convenient for you, and get in touch with the study team.
Please choose between Voice or SMS based delivery of verification code
or